GSK plc GSK
NYSE GSK
$48.68 -0.08 (-0.16%)
At close: Oct 29, 2026 · 4:00 PM EDT

Gsk (GSK) Raw Materials (2013 - 2014)

Updated

Gsk (GSK) posted Raw Materials of $1.8 billion for the quarter ended Dec 31, 2014, up 16.4% from $1.55 billion a year earlier.

Analysis

Gsk (GSK) Raw Materials (2013 - 2014) Analysis & Trends

  • In prior years, Gsk's Raw Materials was $1.55 billion in the year ended Dec 31, 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.17 Bn 1,237.79 Bn 20.46 Bn
2 Johnson & Johnson 660.04 Bn 579.90 Bn 17.30 Bn
3 AbbVie 521.06 Bn 494.17 Bn 12.70 Bn
4 Merck 370.60 Bn 370.60 Bn -
5 Novartis Ag 311.97 Bn 285.20 Bn -
6 Astrazeneca 288.69 Bn 262.37 Bn 12.86 Bn
7 Amgen 252.29 Bn 207.69 Bn 7.24 Bn
8 Gilead Sciences 213.47 Bn 213.47 Bn -
9 Pfizer 173.68 Bn 120.32 Bn 10.94 Bn
10 Gsk 100.27 Bn 83.11 Bn 8.73 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 1.80 Bn
Dec 31, 2013 1.55 Bn
API Access

Gsk Raw Materials API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=raw-materials&ticker=GSK&period=max&api_key=YOUR_API_KEY